chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated that she has history of allergic reaction to flu vaccine (feels weak and couldn't move about 8 years ago) and ever since that, her MD gives her a different flu vaccine.  She discussed with her prmary doctor about the covid vaccine and the doctor recommeneded for her to get the Janssen vaccine. Discussed all possible side effects with her as well as consulted with NP given Janssen vaccine at 11:30AM and was advised to stay for 30 mins for observation. At 11:35 patient stated to close her eyes and look like she was about to pass out.  Patient states she feels light headed. Patient closed her eyes and had to be shaken to be aroused. Responds to yes and no questions but is barely able to talk. Legs eleavted, BP 140/90 HR 81 Sat 100%. Help called, MD and nurses arrived.  Patient's alertness oes up and down, seen by MD, states no need for EMS transport , no anaphylactic reaction noted. 11:40 BP 148/85 HR 62 Sat 98. Coninued to observe patient. 11:45 BP 154/87 Sat 99%. Patient has increased alertness, states she is feeling better. BP 148/80 SAT 99% . 11:55 states she feels dizzy, BP 185/81 HR 66 Sat 100% patient states her BP is high for her (usual BP 90s/60s or 110/70s). Spoke to MD, transferred patient to the back room for further observation. 12:00 supine position BP 149/84 HR 61 Sat100%. Patient conitnues to have on and off dizziness and vitals monitored. 12:10 patient states she feeling better but still weak. BP 137/87 HR 61 Sat 100%. 12:35 paient more alert, able to grip nurses hand with firm grip, talkimg, laughing. BP checked 12:45 sitting up 135/84 sat 100% HR 61. all of a sudden patient states she feels dizzy and started to close her eyes, needs stronger stimulus to arouse patient, EMS called. 12:58 EMS arrived. 1:05 patient taken to hospital via EMS.
Patient received vaccine at outside facility so uncertain of vaccine information other than Moderna.  33 y.o. female who arrived to the emergency department for Chest pain.  Patient states 2 hours PTA she was getting her first Moderna Covid vaccine when she felt the onset of centralized burning chest pain and temporary shortness of breath while sitting in the car.  She states shortness of breath has improved however she feels centralized chest burning that is constant. She denies any palpitations, nausea, vomiting, throat swelling, drooling, or lip swelling.  She has no history of similar symptoms in the past.  No history of GERD.  She has not had no recent illnesses.  She has not taken any new medications  Symptoms clinically most suggestive of chest wall pain versus gastritis.  Patient given GI cocktail and Toradol.  Baseline EKG was normal sinus rhythm without any ST elevation or depression. Heart score 0  Pt with improvement with GI cocktail and Toradol, clinically confirmatory for chest wall pain vs reflux. Recommend home tylenol and/or pepcid if sx persist. Follow up PCP if recurrent sx or ED if severe
A week after the vaccine #2, I had a severe flare up of IBS, with daily moderate to severe stomach pain.  Also had a flare up of osteoarthritis pain, plus unusual fatigue.
Patient received vaccine in afternoon 11/4. At 2300 on 11/5, developed some congestion and an acute coughing episode productive of pinkish phlegm. Family gave some eucalyptus syrup which she was able to swallow.  Cough suddenly stopped at which point patient became nonresponsive with color change. 911 called, brought to Medical Center. Noted to be hypoxic and have barking cough. Developed acute hypoxemic respiratory failure requiring emergency intubation and she was transferred to Medical Center where she has remained on a ventilator.
PATIENT GIVEN AN EXPIRED HEPATITIS A VACCINE   EXPIRATIONS DATE 2/6/2023
Patient was tested positive for COVID-19 infection after the first dose; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Patient was tested positive for COVID-19 infection after the first dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient was tested positive for COVID-19 infection after the first dose). At the time of the report, COVID-19 (Patient was tested positive for COVID-19 infection after the first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received on 10-MAY-2021 had no new information. On 16-Jul-2021: Follow-up received on 16-Jul-2021, in which No new information is given.
really weird something with my right leg; pain in my right leg in two spots,two different muscles: thigh and calf; could figure out was that it was muscular, almost like I pulled a muscle; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (really weird something with my right leg), PAIN IN EXTREMITY (pain in my right leg in two spots,two different muscles: thigh and calf) and MYALGIA (could figure out was that it was muscular, almost like I pulled a muscle) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced LIMB DISCOMFORT (really weird something with my right leg), PAIN IN EXTREMITY (pain in my right leg in two spots,two different muscles: thigh and calf) and MYALGIA (could figure out was that it was muscular, almost like I pulled a muscle). At the time of the report, LIMB DISCOMFORT (really weird something with my right leg), PAIN IN EXTREMITY (pain in my right leg in two spots,two different muscles: thigh and calf) and MYALGIA (could figure out was that it was muscular, almost like I pulled a muscle) had resolved.            Patient was treated with physical therapy and acupuncture.  Patient had undergone tons of medical tests but none of them showed how it happened.  No concomitant drug details were reported.    This case was linked to MOD-2021-434057 (Patient Link).
Around 3 inches below the vaccine injection site Itching, redness, swelling, area feels warm  to touch even 12 days after vaccination
Coughing , sneezing, vomiting, diaherra , shortness of breath and weakness, pass out fits
Sore arm; exhaustion; I have uncontrolled rheumatoid arthritis and thought I was cured. All RA symptoms gone; 2nd shot: Hypomanic for 4 glorious hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: er 8729) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing), notes: Rheumatoid Arthritis; "Known allergies: Beta Blocker Medication" (unspecified if ongoing), notes: Known allergies: Beta Blocker Medication; "COVID-19" (unspecified if ongoing), notes: If Covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st shot: Hypomanic for 2 hours, Other vaccine same date details:, Other vaccine same date Product=Pfizer, Other vaccine same date Lot number= er 8737, Other vaccine same date Dose number= 1, Other vaccine same date Vaccine location= Left arm.), for Covid-19 immunisation, reaction(s): "Hypomanic for 2 hours". The following information was reported: HYPOMANIA (non-serious), outcome "recovered", described as "2nd shot: Hypomanic for 4 glorious hours"; PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Sore arm"; FATIGUE (non-serious), outcome "recovered", described as "exhaustion"; THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "recovered", described as "I have uncontrolled rheumatoid arthritis and thought I was cured. All RA symptoms gone". Therapeutic measures were not taken as a result of hypomania, pain in extremity, fatigue, therapeutic response unexpected.  No follow-up attempts are possible. No further information is expected.
Having the cold; Chills; Low grade fever; Achy; Exhausted; Sore arm; Joint aches / Arthritic feeling / arthritic feeling in her knuckles; This case was reported by a consumer via call center representative and described the occurrence of joint pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included eye dryness.   On 15th March 2019, the patient received the 1st dose of Shingrix .5 ml. On 15th March 2019, less than a day after receiving Shingrix, the patient experienced joint pain. On 16th March 2019, the patient experienced feeling cold, chills, fever, pain, exhaustion and pain in arm. On 16th March 2019, the outcome of the feeling cold, chills, fever, pain, exhaustion and pain in arm were recovered/resolved. On an unknown date, the outcome of the joint pain was recovered/resolved.   It was unknown if the reporter considered the joint pain, feeling cold, chills, fever, pain, exhaustion and pain in arm to be related to Shingrix.  Additional case details were reported as follows: The patient got the first Shingrix dose in the morning of 15th March 2019 and patient started having the symptoms that same night, joint aches (like arthritic feeling in her knuckles).  The next day 1 day after receiving Shingrix, the patient woke up with the following symptoms: feeling like having the cold, chills, low grade fever, achy, exhausted, arm was sore.  The symptoms were disappeared within a day or so except for the sore arm, which lasted a longer time. The reporter did not consent to follow up.
Patient developed swelling, redness, and warmth to left upper arm soon after receiving vaccinatinos. Also had fever to 102. Suspected arthus reaction but could not rule out cellulitis. Treated with Clindamycin and antihistamines. MMR vaccine wsa given in the R thigh and all others in L arm. Elsewhere in the same record it is noted that per a call to the immunization clinic, their general procedure is to give DTaP and IPV in L arm, MMR in R arm and Flu/Hep A in either arm. Per annual report- I have not had contact with this patient since they were discharged from the hospital.
Pt had a fever for 1 week, treated with Tylenol. He had a loss of weight and appetite over a period of 6 weeks and loose bowels for 4-5 weeks and he also stopped walking for 2 weeks.
couple hours after vaccine started getting a headache had a fever of 104.8, chills, sweating, rapid heartbeat, seeing flutters, left side of face swollen
The symptoms of the trigeminal neuralgia very suddenly became worse in the month following the shot. Before attacks would be every few months and we?re controlled by medication. After October attacks came multiple times a day and medicine no longer worked. Eating, talking, and drinking at times have been impossible.
Patient developed Bell's palsy 3-4 days after receiving the Hep A vaccination.  I do not know the name of the manufacturer or the details of the Hep A vaccination.  I do know it was his first dose of Hep A.  We were referred to a neurologist immediately when our pediatrician suspected patient has Bell's palsy.  We were seen later that day.  (I think it was July 2, 2018.)  The neurologist confirmed the pediatrician's diagnosis and prescribed steroids.  We were also required to put eye drops in patient's eye and have him wear an eye patch since he wasn't able to close his eye completely.  After about a week on medication, patient began to show signs of improvement.  We were told to follow up with our pediatrician which we did.  No further treatment was given since he was improving.  He appears to have made a complete recovery from Bell's palsy.
Had / the 2 shringrex shots and still got the shingles, Suspected vaccination failure; Had / the 2 shringrex shots and still got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingles vaccine, the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingles vaccine, Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient was vaccinated with Shingles vaccine plus the 2 Shingrix shots and still got the shingles. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were not provided.
Patient was given a second dose of fluarix on 9/29/2023 patient had already received vaccine on 09/26/2023 patient parents aware. Child doing okay no problems per parents. Spoke with Dr who is precepting advised parents be notified no adverse reaction reported
This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unknown age and race/ethnicity received a dose of Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein) at single dose on unknown date, via an unspecified route of administration for immunization. Relevant medical history and concomitant medications were unknown. On unknown date the patient experienced that she can lift her arm but it hurts and she noticed that her arm blew up for three days. The outcome of the event was unknown. Information on the batch number has been requested. Pfizer is Marketing Authorization Holder of Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein) in the reporter's country. This may be a duplicate report in situations where another Marketing Authorization Holder of Pneumococcal 13-Val Conj Vac (Dipht CRM197 Protein) has submitted the same report to the regulatory authorities.
Faint with brief loss of consciousness for about 10-15 seconds right after vaccination. The skin is clammy and cold. Denies history of vaccine-related reactions,seizures. Regains consciousness quickly and completely without sequelae.Leaves the premise under ambulatory status after being watched by physician for 30 minutes.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2022 as dose 5 (booster), single (Lot number: gj2524) at the age of 51 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 20Feb2021 as dose 1, single (Lot number: EL9262), in right arm, on 13Mar2021 as dose 2, single (Lot number: en6208), in right arm, on 28Sep2021 as dose 3 (booster), single (Lot number: fc3182), in left arm and on 15Apr2022 as dose 4 (booster), single (Lot number: fk9894) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of covid-19, vaccination failure which included Paxlovid taken from 01Dec2022 to 06Dec2022.
Narrative:  Patient was not previously COVID-19 positive and did not have any  predisposing factors(PMH, allergies, ect.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death.  PMh significant for multiple nodules of the lung, hypertension, abnormal liver functions tests. No notation regarding death, or recent hospitalizations.
Patient seen in clinic on 6/5/14 and was noted to have erythema and swelling covering the deltoid region of the left arm which Dr noted was a local reaction to immunization. Patient advised to use TYLENOL or ibuprofen for discomfort as well as cold packs if needed for 15 min. at a time.
pt recv vax 23AUG95 & 16JAN96 pt devel a chickenpox rash;It was noted on 3JAN96 pt sibling who had also been vaccinated w/varicella on 23AUG95 devel chickenpox (WAES96010271)
I had the shot in my left arm. My Arm was stiff, painful( pain thought out the left arm). The arm upper  area was a huge bump for about 6 days. Now as of today still having pain and have tenderness in the left arm/ shoulder. The pain at times is about a 7  from 1 - 10 scale  at some times. I have been taking pain killers, helps , but can't keep taking pain killers.
Approx 12:30 PM same day..excrutiating pain in left shoulder..unable to move arm at all...used ice and Tylenol..didnt help almost went to ER but waited till next morning..called DR and they said use 600 mg ibuprofen. Pain was so bad first 48 hours could not stop tears...could not sleep..this is now Fri..1/13/12   have regianed about 65% range of motion..still hurts all the time.
Initial report was received from a healthcare professional on 29 March 2013. A four-year-old patient had received an injection of DIPHTHERIA, TETANUS AND PERTUSSIS VACCINE (trade name, manufacturer, lot number, route, site and date of administration not reported) and one week later had a "mini-stroke". The patient was hospitalized for two weeks. No additional information was available. Outcome was recovered. Documents held by sender: None.
My son had a couple more doses left of the amoxicillin left when these vaccines were given at his well check visit the following week after we brought him in for the ear infection. I had specifically questioned about the vaccines as I was worried about him still taking the final doses of the medication prescribed. All involved assured me it would be safe. Once home the next week he developed a high fever, rash (like Measles) diarrhea and within the week a massive yeast infection so bad it was foaming out of his mouth and but. For the next almost three months he was in and out of the doctor's office. He developed a double ear infection and was sick/ lethargic for a long time. His doctor never reported to VAERS but insisted he must have has a reaction to the antibiotic. I was never informed of VAERS until recently like the last two years. After he was getting better we noticed he would ignore us like he could not hear us. He lost the few words he had developed and started shying away from his sister, cousins and his father a lot. He was a babbler and a ham early on but after this illness he was not the same outgoing little boy. He was not talking or engaging with us as much and every time I asked his doctor about it she would say boys are different and it's been a long time since you had a baby. He will catch up (we have a 12 year gap between him and his older sister). When we finally decided to get him into preschool the teachers suspected Autism right away.
Unknown if related to the vaccine..however approximately 3 weeks after receiving the first dose of the vaccine, I had a subarachnoid hemmorhage and was airlifted to Medical Center.  The source of the brain bleed was never found.  5 days and two angiograms later, I was released and sent home.    Was in good health prior to the aneursym and returned to work as a police officer 8 weeks later.  No lasting affects.
This was the booster / received Jansen 5/8/21 - experienced rapid heart rate
This spontaneous report was received from a pharmacist via a company representative refers to a male patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and lot # not reported). "6 weeks' after the patient received ZOSTAVAX he developed a "pulling" sensation in his arm. The reporter stated "when the patient raises his arm he got a pulling sensation". It was unknown if the patient had sought medical attention. The outcome of the event and action taken with suspect therapy was unknown. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of injection site warmth in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 15th November 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 15th November 2021, immediately after receiving Shingrix, the patient experienced injection site pain. On 16th November 2021, the patient experienced injection site erythema. On 17th November 2021, the patient experienced injection site warmth and injection site swelling. The patient was treated with steroids nos (Steroid (Not Specified)) and antibiotics nos (Antibiotic (Active Ingredient Unknown)). On an unknown date, the outcome of the injection site warmth, injection site swelling and injection site erythema were recovered/resolved and the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site warmth, injection site swelling, injection site erythema and injection site pain to be related to Shingrix. Additional details were provided as follows: The patient is the reporter. The age at vaccination was not reported. The patient received her first Shingrix dose on 15th November 2021 and immediately had arm pain at the injection site. The patient stated the pain had lessened and she only had injection site arm pain if her arm was bumped. On 16th November 2021 she also had redness at the injection site. On 17th November 2021 she also had swelling and hot skin at the injection site. She went to an urgent care facility and was prescribed a steroid and antibiotic. The redness, swelling and hot skin resolved 4 to 5 days later. She had nothing else to report. The reporter consented to follow up.
a patient received improperly stored vaccine on 4/24/2019; Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history, drug reactions or allergies were not reported.  On 24-APR-2019, the patient was administered a dose of improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(PEDVAXHIB) (lot number: R021078; expiration date: 12-JUN-2021; strength and route were not reported) and a dose improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot number: R028189; expiration date: 06-JUN-2020; strength and route were not reported) for prophylaxis. The temperature of storage was 52.5 degrees Fahrenheit for 4 hours and 40 minutes. There was no previous temperature excursion. Data logger was involved. The outcome of the event was unknown.